Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Reichert

Showing results (71-80 of 437) with videos related to

Pageof 44
Sort By:
Radiologic Technology|November 1, 1994
MR imaging of pineoblastomasK Lambrinides, M Reichert
OR Manager|October 28, 1999
Sterilization & infection control. Which process is best to use?M Reichert, J K Schultz
OR Manager|May 7, 1998
Key decisions on device reprocessingM Reichert, J K Schultz
OR Manager|November 3, 1997
Sterilization & infection control. Are all your point-of-use processes in line?M Reichert, J K Schultz
Nature Biotechnology|June 29, 2002
Therapeutic cancer vaccines on trialJanice M Reichert, Cherie Paquette
Mabs|July 26, 2011
Therapeutic Fc-fusion proteins and peptides as successful alternatives to antibodiesAlain Beck, Janice M Reichert
Acta Biochimica Polonica|January 1, 1991
Molecular cloning of provirus DNA from bovine leukaemia lymphocytes and its application as a probe for diagnostic purposeM Reichert, J Grundboeck-Juśko
Biophysical Journal|February 1, 1994
Analysis of protein binding to receptor-doped lipid monolayers by Monte Carlo simulationS Zhao, W M Reichert
Mabs|January 5, 2018
Antibodies to watch in 2018Hélène Kaplon, Janice M Reichert
Mabs|January 16, 2014
Antibody-drug conjugates: present and futureAlain Beck, Janice M Reichert
Pageof 44

Showing results (71-80 of 437) with videos related to

Sort By:
Pageof 44
Radiologic Technology|November 1, 1994
MR imaging of pineoblastomasK Lambrinides, M Reichert
OR Manager|October 28, 1999
Sterilization & infection control. Which process is best to use?M Reichert, J K Schultz
OR Manager|May 7, 1998
Key decisions on device reprocessingM Reichert, J K Schultz
OR Manager|November 3, 1997
Sterilization & infection control. Are all your point-of-use processes in line?M Reichert, J K Schultz
Nature Biotechnology|June 29, 2002
Therapeutic cancer vaccines on trialJanice M Reichert, Cherie Paquette
Mabs|July 26, 2011
Therapeutic Fc-fusion proteins and peptides as successful alternatives to antibodiesAlain Beck, Janice M Reichert
Acta Biochimica Polonica|January 1, 1991
Molecular cloning of provirus DNA from bovine leukaemia lymphocytes and its application as a probe for diagnostic purposeM Reichert, J Grundboeck-Juśko
Biophysical Journal|February 1, 1994
Analysis of protein binding to receptor-doped lipid monolayers by Monte Carlo simulationS Zhao, W M Reichert
Mabs|January 5, 2018
Antibodies to watch in 2018Hélène Kaplon, Janice M Reichert
Mabs|January 16, 2014
Antibody-drug conjugates: present and futureAlain Beck, Janice M Reichert
Pageof 44